FR Doc E8-18055[Federal Register: August 6, 2008 (Volume 73,
Number 152)] [Notices] [Page 45781] From the Federal Register
Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06au08-86]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing
a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21
U.S.C. 952(a)(2) authorizing the importation of such a
substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal
Regulations (CFR), 1301.34(a), this is notice that on June 5,
2008, Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy
Drive, Petersburg, Virginia 23805, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a basic class of controlled
substance listed in schedule II.
The company plans to import the listed controlled substance
to bulk manufacture amphetamine.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of
controlled substance may file comments or objections to the
issuance of the proposed registration and may, at the same time,
file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, VA. 22152; and must be filed no
later than September 5, 2008.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21
CFR 1301.34(b), (c), (d), (e), and (f). As noted in a
previous notice published in the Federal Register on September
23, 1975, (40 FR 43745), all applicants for registration to
import a basic class of any controlled substance in schedule I
or II are, and will continue to be, required to demonstrate to
the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-18055 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).